Insurance industry cost-control measures may be worsening the nation’s opioid epidemic by limiting access to a key medication that treats addiction, according to experts.
Insurance industry cost-control measures may be worsening the nation’s opioid epidemic by limiting access to a key medication that treats addiction, according to experts.